C-reactive protein-to-albumin ratio predicts survival in hepatocellular carcinoma on atezolizumab plus bevacizumab.
Mayumi Ehara
Toshifumi Tada
A. Morii
K. Aoe
Tatsuya Sakane
Naoki Shinmaru
Y. Inoue
Jun Kitadai
Yu Shiomi
T. Matsuura
Masaki Omori
Motochika Hamanaka
Shohei Komatsu
Takashi Nishimura
Yuzo Kodama
Medicine